Today: 19 May 2026
Beazley share price today: stock edges up as Zurich takeover deadline nears
12 February 2026
1 min read

Beazley share price today: stock edges up as Zurich takeover deadline nears

London, Feb 12, 2026, 08:39 GMT — Regular session

Beazley Plc shares ticked higher Thursday morning, adding about 0.4% to reach 1,232 pence as of 0838 GMT. New disclosures of takeover positions continued to stoke deal speculation.

Beazley shares jumped into focus after Lloyd’s of London’s insurer and Zurich Insurance Group said they’d hammered out the main financial terms for what could become a recommended cash bid. If it goes ahead, the offer would peg Beazley at up to 1,335 pence a share, dividends included.

The stock trades more like a wager on specific outcomes than a typical insurance name. Right now, even a minor shift of a few pence captures speculation on timing and probability—premium rates or claims barely register in the action.

FMR LLC and FIL Limited—both linked to Fidelity—disclosed a 3.70% stake in Beazley as of Feb. 10, according to a recent filing. The same document shows recent Beazley share sales, prices coming in between £12.3 and £12.4.

Citing a Form 8.3, Citadel Group disclosed a 2.02% stake in Beazley, largely via cash-settled derivatives. The firm also flagged a small short.

Cash-settled derivatives move with a stock’s price, but there’s no exchange of the actual shares—settlement happens in cash. Traders lean on these instruments in takeover situations, particularly in merger arbitrage, to wager on the gap between a stock’s trading level and a bidder’s offer.

Under the UK Takeover Code, once a company is in play, investors holding sizable positions must file Form 8, disclosing their stakes. For traders, these filings crack open a view of how crowded the trade is and what kind of leverage is backing it.

The dangers here are pretty obvious. If Zurich doesn’t push forward, shares risk a sharp drop as backing for the deal fades. And stalled talks? That discount could linger, bid or no bid down the line.

Beazley hasn’t put out a formal offer document or set any timeline. That leaves the door open for more disclosures, while investors are still counting up the backing.

Zurich has until 5 p.m. London time on Feb. 16 to make its move—either officially announce an offer for Beazley or step aside, in line with UK takeover rules.

Stock Market Today

  • Lululemon Proxy Fight Weighs on Stock Price
    May 19, 2026, 6:11 AM EDT. Lululemon Athletica Inc's ongoing proxy battle between the company and its founder is creating uncertainty in the market. The contest involves control over the board of directors, which affects strategic direction. Investors are cautious as leadership disputes often signal potential shifts in governance and influence operational priorities. This proxy fight has contributed to pressure on Lululemon's stock price, reflecting concern about the company's stability. Shareholder disagreements may distract from growth initiatives in the competitive athletic apparel sector. Analysts track this conflict closely, noting that resolution could impact investor confidence and stock performance.

Latest articles

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

Hesai Stock Rises Before the Bell as Mercedes Lidar Deal Meets Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

19 May 2026
NextEra Energy agreed to acquire Dominion Energy in a $66.8 billion all-stock deal, sending Dominion shares up 9.4% to $67.56 while NextEra fell 4.6%. Dominion holders would get 0.8138 NextEra share per Dominion share and a $360 million cash payment. The deal requires multiple regulatory approvals. Dominion’s Coastal Virginia Offshore Wind project remains a focus after cutting costs to $11.4 billion.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 12.02.2026

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Next Story

Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus

Go toTop